Further evidence that nitric oxide modifies acute and chronic morphine actions in mice

European Journal of Pharmacology

Volumn 357, Issue 2-3, 1998, Pages 157-162

  Pataki, Imre ^a   Telegdy, Gyula ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Dependence; L Arginine; Morphine; N( ) nitro L arginine; Nitric oxide (NO); Tolerance

Indexed keywords

ARGININE; MORPHINE; N(G) NITROARGININE; NALOXONE; NITRIC OXIDE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; DRUG DEPENDENCE; DRUG EFFECT; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANALGESIA; ANIMALS; ARGININE; DRUG TOLERANCE; ENZYME INHIBITORS; MALE; MICE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; TIME FACTORS;

EID: 0032544758     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00561-5     Document Type: Article

References (15)

1. Babey A.M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1994;1463-1470.
2. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
3. Cappendijk S.L.T., de Vries R., Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162:1993;97-100.
4. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
5. Duarte I.D.G., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 221:1992;171-174.
6. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
7. Kolesnikov Y., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. USA. 94:1997;8220-8225.
8. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
9. Minneman K.P., Iversen L.L. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature. 262:1976;313-314.
10. Pasternak G.W., Kolesnikov Y.A., Babey A.M. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology. 13:1995;309-313.
11. Przewlocki R., Machelska H., Przewlocka B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal chord. Life Sci. 53:1993;PL1-PL5.
12. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
13. Vaupel D.B., Kimes A.S., London E.B. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315-322.
14. Xu J.Y., Tseng L.F. Increase of nitric oxide by L-arginine potentiates β-endorphin- but not μ-, δ- or κ-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmacol. 236:1993;137142.
15. Xu J.Y., Tseng L.F. Nitric oxide/cyclic guanosine monophosphate system in the spinal chord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 274:1995;8-16.